Arena Pharmaceuticals, Inc. (ARNA)

[flybucks]

the posts here have mixed flavor....luv the SciGuy question and lovethatgreen response....those bring healthy discussions.

but....let's say i want to play this both as day trade and swing thru approval and are sweating every dime movement like we know at least one poster is doing....gotcha

what i wanna hear is.....

why the secondary offering....and not from the company who is probably legally constrained from stating more than the obvious released in their public announcement....but from seasoned investors like yourselves who may be suspicious...or not... as to why they did a relatively cheap offering at $5.50 now....instead of waiting for bigger bucks post approval. this smaller offering of just 11m shares does offer some consolation to longs but still....

what is guestimated post-approval stock value (max spike and settle prices)....considering the Esai % agreement, the possibility of CVOT if not REMS... maybe a quick bounce to $15 and back to $9 just like our retracement $7.80 to $5.44 or are we really in a blockbuster $20-$40+ DNDN or ITMN category?

holding long-term can be hazardous to a portfolio even when a company gains approval....so are we really hear to talk DD or is it we want to know how to gauge the market's immediate and long-term reaction to various contingencies such as short interest, possible delays, REMS or CVOT, buyout tempered by Esai's agreement, and share count potentially going astronomical....

warding off the P&Ds with challenging discussions on these important DD issues is fine but what i want, and i bet most others want, even more from this board is their trading experiences reference similar setups....for example is large short interest negated by high volume/high premium options that just expired priming stock for price surge....or just the opposite.... a slow rollover filling the gap down to the 3s?

keep it alive